The diagnosis of SLE is a significant challenge, as symptoms can fluctuate and sometimes mimic those of other diseases. Furthermore, there is currently no test available that can diagnose SLE with ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...